Literature DB >> 28387861

Lower Pressure Pain Thresholds in Patellofemoral Pain Patients, Especially in Female Patients: A Cross-Sectional Case-Control Study.

Rianne A van der Heijden1, Melissa M Rijndertse1, Sita M A Bierma-Zeinstra1, Marienke van Middelkoop1.   

Abstract

Objective: It has been suggested that repeated overload might sensitize nociceptors, causing local hyperalgesia in patients with patellofemoral pain (PFP). This might also lead to generalized hyperalgesia, indicative of altered central pain processing. This study aimed to investigate differences in pressure pain threshold (PPT) as a measure of pressure hyperalgesia between patients with PFP and healthy controls and in predefined subgroups and to study associations between PPT and patient characteristics. Design: Case-control study. Setting: Physiotherapy, general practices, and sports medicine practices. Subjects: Sixty-four patients with PFP and 70 healthy controls.
Methods: Demographics, pain (numerical rating score), and function (anterior knee pain score) were obtained by questionnaire. The PPT was measured with a handheld dynamometer with algometry tip at the most painful spot of the affected knee (medial facet in controls), the same spot at the contralateral knee, and at the contralateral forearm. Differences between groups were tested using analysis of variance techniques including the variables age, gender, body mass index, and sports participation.
Results: Patients had significantly lower PPTs compared with controls at all locations (affected knee: mean difference = -12.2, 95% confidence interval [CI] = -17.3 to -7.1; contralateral knee: mean difference = -4.7, 95% CI = -10.1 to 0.52; contralateral arm: mean difference = -5.7, 95% CI = -10.5 to -0.8). Both male and female patients demonstrated lower PPTs, though a significant subgroup effect was found for female gender (effect size ranging from 0.73 to 0.98). Conclusions: Local and generalized pressure hyperalgesia, suggesting alterations in both peripheral and central pain processing, were present in patients with PFP, though females with PFP were most likely to suffer from generalized hyperalgesia.
© 2017 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Hyperalgesia; Knee Pain; Patellofemoral Pain Syndrome

Mesh:

Year:  2018        PMID: 28387861     DOI: 10.1093/pm/pnx059

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  5 in total

1.  Pressure algometry is a suitable tool to assess anterior knee pain in osteoarthritic patients.

Authors:  Pedro Hinarejos; Nerea Goicoechea; Mauricio Gidi; Joan Leal-Blanquet; Raul Torres-Claramunt; Juan Sánchez-Soler; Joan Carles Monllau
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-02-07

2.  Exploring the Pain in Patellofemoral Pain: A Systematic Review and Meta-Analysis Examining Signs of Central Sensitization.

Authors:  Kemery J Sigmund; Marie K Hoeger Bement; Jennifer E Earl-Boehm
Journal:  J Athl Train       Date:  2021-08-01       Impact factor: 3.824

3.  Psychological and Pain Sensitization Characteristics Are Associated With Patellofemoral Osteoarthritis Symptoms: The Multicenter Osteoarthritis Study.

Authors:  Natalie J Collins; Tuhina Neogi; Bill Vicenzino; Ali Guermazi; Frank W Roemer; Cora E Lewis; James C Torner; Michael C Nevitt; Joshua J Stefanik
Journal:  J Rheumatol       Date:  2020-03-01       Impact factor: 4.666

4.  Quantitative volume and dynamic contrast-enhanced MRI derived perfusion of the infrapatellar fat pad in patellofemoral pain.

Authors:  Rianne A van der Heijden; Bas A de Vries; Dirk H J Poot; Marienke van Middelkoop; Sita M A Bierma-Zeinstra; Gabriel P Krestin; Edwin H G Oei
Journal:  Quant Imaging Med Surg       Date:  2021-01

5.  Optimizing Rehabilitation and Return to Sport in Athletes With Anterior Knee Pain Using a Biomechanical Perspective.

Authors:  Brian J Theisen; Peter D Larson; Caitlin C Chambers
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.